Correspondence 0001193125-24-281362 from Forte Biosciences, Inc. (FBRX)
Forte Biosciences, Inc.
Date: Dec. 18, 2024 · CIK: 0001419041 · Accession: 0001193125-24-281362
AI Filing Summary & Sentiment
File numbers found in text: 333-283814
Letter
December 18, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-3720
Attn: Tim Buchmiller
Re: Forte Biosciences, Inc.
Registration Statement on Form S-3
File No. 333-283814
Acceleration Request
Requested Date: December 20, 2024
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Forte Biosciences, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-283814) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Dan Koeppen at (858) 350-2393 or via email at dkoeppen@wsgr.com.
Sincerely,
FORTE BIOSCIENCES, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP December 18, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-3720 Attn: Tim Buchmiller Re: Forte Biosciences, Inc. Registration Statement on Form S-3 File No. 333-283814 Acceleration Request Requested Date: December 20, 2024 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Forte Biosciences, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-283814) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Dan Koeppen at (858) 350-2393 or via email at dkoeppen@wsgr.com. Sincerely, FORTE BIOSCIENCES, INC. /s/ Paul A. Wagner, Ph.D. Paul A. Wagner, Ph.D. Chief Executive Officer cc: Dan Koeppen, Wilson Sonsini Goodrich & Rosati, P.C.